OUR OFFERING:
1) A high return on your investment — access to promising, longevity-focused talent of varying backgrounds and areas of scientific focus with little required input.
2) A symbiotic, cyclical relationship: As we win, you win.
3) Investment in our conjoined future: the next generation of longevity entrepreneurs and scientists.
OUR ASK:
To move onward, upward, and to make and keep P//A as accessible as possible, we need:
1) Sponsorship and/or investment
2) Mentoring
3) Connection with companies, investors, and Web3/DeSci communities who are genuinely interested in creating a pipeline of talent in longevity research.
“Longevity is the biggest investment opportunity of our time, and will radically change the way of pharma.”
Robin Lauber
Chairman and CEO of Infinitas Capital
